PEPTONIC MEDICAL (28L) — Net Asset Quality Index
PEPTONIC MEDICAL (28L) has a Net Asset Quality Index of 80.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €60.76 Million minus total liabilities of €11.59 Million yields net assets of €49.17 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read total liabilities of PEPTONIC MEDICAL for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
PEPTONIC MEDICAL Net Asset Quality Index Over Time (2021–2025)
This chart shows how PEPTONIC MEDICAL's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 80.9%, representing net assets of €49.17 Million against total assets of €60.76 Million EUR. For live market cap and overall valuation, see 28L market cap overview.
Annual Net Asset Quality Index for PEPTONIC MEDICAL (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for PEPTONIC MEDICAL from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See 28L book value for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 58.0% | €38.24 Million | €65.92 Million | €27.67 Million | ▼ -10.8 pp |
| 2024 | 68.8% | €48.55 Million | €70.56 Million | €22.01 Million | ▼ -1.8 pp |
| 2023 | 70.6% | €75.32 Million | €106.74 Million | €31.41 Million | ▲ +15.7 pp |
| 2022 | 54.9% | €47.09 Million | €85.75 Million | €38.66 Million | ▼ -7.9 pp |
| 2021 | 62.8% | €53.12 Million | €84.60 Million | €31.48 Million | — |